Description

Zilberberg et al reported a bedside instrument for identifying Gram-negative pathogens that are carbapenem resistance in a patient with a complicated urinary tract infection. The authors are from the University of Massachusetts Amherst, Optistatim, The Medicines Company, Melinta Therapeutics and Washington Hospital Center.


Patient selection: adult with complicated urinary tract infection with Gram-negative pathogens

 

Gram-negative pathogens: Pseudomonas aeruginosa, Acinetobacter baumannii, Stenotrophomonas maltophilia, Enterobacteriaceae

 

Carbapenem resistance: intermediate or complete resistance to imipenem, meropenem, ertapenem, doripenem

 

Parameters:

(1) history of weight loss

(2) admission from an extended-care facility

(3) early mechanical ventilation

(4) age in years

(5) sex

(6) catheter-associated UTI

(7) prior antibiotic therapy

(8) prior infection with a carbapenem-resistant organism

 

Parameter

Finding

Points

history of weight loss

no

0

 

yes

1

admission from ECF

no

0

 

yes

1

early mechanical ventilation

no

0

 

yes

1

age

< 50 years

2

 

>= 50 years

0

sex

male

3

 

female

0

catheter-associated UTI

no

0

 

yes

4

prior antibiotic therapy

no

0

 

yes

4

prior infection with carbapenem resistant organism

no

0

 

yes

8

 

total score =

= SUM(points for all 8 parameters)

 

Interpretation:

minimum score: 0

maximum score: 24

The higher the score the greater the risk of carbapenem resistance.

 

Score

Percent Resistant

0 to 2

1%

3

2-3%

4 or 5

4-5.5%

6 or 7

6%

8 or 9

7-8.5%

>= 10

14-15%

 

Performance:

The area under ROC curve is 0.72.


To read more or access our algorithms and calculators, please log in or register.